Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period

Phase: N/A Priority: Normal
NCT ID: NCT00723983 Org: User:
Start: 11/30/08 End: 09/30/09 Due: 09/30/10

Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01381796 Org: User:
Start: 12/31/09 End: 09/30/10 Due: 09/30/11

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

Phase: N/A Priority: Normal
NCT ID: NCT00724815 Org: User:
Start: 01/31/09 End: 07/31/09 Due: 07/31/10

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months

Phase: N/A Priority: Normal
NCT ID: NCT00792103 Org: User:
Start: 01/31/09 End: 09/30/10 Due: 09/30/11

Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine

Phase: N/A Priority: Normal
NCT ID: NCT02684409 Org: User:
Start: 08/31/13 End: 11/30/14 Due: 11/30/15

Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®

Phase: N/A Priority: Normal
NCT ID: NCT00546650 Org: User:
Start: 11/30/07 End: 03/31/08 Due: 03/31/09

Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00720018 Org: User:
Start: 06/30/08 End: 07/31/08 Due: 07/31/09

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

Phase: N/A Priority: Normal
NCT ID: NCT00806546 Org: User:
Start: 02/28/09 End: 05/31/11 Due: 05/31/12